Cargando…
Bee Venom Phospholipase A(2): Yesterday’s Enemy Becomes Today’s Friend
Bee venom therapy has been used to treat immune-related diseases such as arthritis for a long time. Recently, it has revealed that group III secretory phospholipase A(2) from bee venom (bee venom group III sPLA(2)) has in vitro and in vivo immunomodulatory effects. A growing number of reports have d...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773801/ https://www.ncbi.nlm.nih.gov/pubmed/26907347 http://dx.doi.org/10.3390/toxins8020048 |